Earnings Preview: Lisata Therapeutics
Portfolio Pulse from Benzinga Insights
Lisata Therapeutics (NASDAQ:LSTA) is set to release its quarterly earnings report on November 2, 2023. Analysts estimate an earnings per share (EPS) of $-0.93. The company's stock performance has been generally negative over the last 52-week period, with shares down 46.95%. Last quarter, the company beat EPS by $0.20, which was followed by a 0.0% drop in the share price.
November 01, 2023 | 7:01 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Lisata Therapeutics is expected to report an EPS of $-0.93 in its upcoming earnings. The company's stock has been performing negatively, with a 46.95% drop over the last 52 weeks.
The company's stock has been performing negatively over the past year, which could indicate investor skepticism. The estimated EPS of $-0.93, if accurate, could further impact the stock negatively.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100